Novartis Institutes for Biomedical Research
Europe, Basel-Stadt, Switzerland, Basel
Description
Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis
Investor Profile
Novartis Institutes for Biomedical Research has backed more than 8 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 13% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series B (50%)
- Series A (38%)
- Series C (13%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Medical Device
- Wellness
- Oncology
- Health Diagnostics
- Recruiting
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
